USPTO serial 88232534
4C
Reviewed by CopyMark Law Group
Reg. 5871682Status 710
- Filing date
- Status date
- Registration date
- Oct 1, 2019
- Examiner
- WILKE, JOHN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with 4C?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Piscataway, NJ, US
Piscataway, NJ, US
Piscataway, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy X. Gibson
TIMOTHY X. GIBSON GIBSON & DERNIER LLP125 HALF MILE ROADSUITE 200RED BANK, NJ 07701Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services | SECTION 8 - CANCELLED | Sep 8, 2018 |
| 041 | Training services in the field of pharmacovigilance and regulatory compliance | SECTION 8 - CANCELLED | Sep 8, 2018 |
| 042 | Technical writing for others; technical writing in the field of medical writing; searching and retrieving information, sites, and other resources available on computer networks for others; consulting services for others in the field of design, planning, and implementation project management of clinical trials and pharmacovigilance; installation and maintenance of pharmacovigilance computer software; tracking and monitoring of safety and/or efficacy for drugs, devices, drug/device combinations, biologics, biosimilars, cosmetics, nutraceuticals or consumer products for others for pharmacovigilance purposes | SECTION 8 - CANCELLED | Sep 8, 2018 |
| 044 | Providing medical information in the field of pharmacovigilance and clinical trials | SECTION 8 - CANCELLED | Sep 8, 2018 |
| 045 | Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics | SECTION 8 - CANCELLED | Sep 8, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks owned by 4C Pharma Solutions LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named 4C
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 1, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 1, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 13, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 30, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 30, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 30, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 30, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 30, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 30, 2019 | ISSR | WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | — |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2019 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 20, 2018 | NWAP | NEW APPLICATION ENTERED | — |